Clin2
NCT06856161Possibly a fitRecruiting

Blood test to help diagnose mental health conditions

Depression - Major Depressive DisorderSchizophenia DisorderPsychosisMania (Neurotic)Alcohol ConsumptionAnxiety Disorder (Panic Disorder or GAD)Substance Use DisordersAlcohol Use Disorder

Part of Brain & nervous system, Mental health clinical trials.

This study is testing a new blood test that might help doctors better understand and diagnose conditions like depression, psychosis, or schizophrenia. If you are 19 or older and have one of these conditions, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
19 years and older
Study type
Observational

Who can take part

  • You are 19 years old or older.
  • You have or may have depression, or you have or may have psychosis or schizophrenia.
  • You are able to fill out mental health questionnaires.
  • You are not currently in another drug or device study that could affect your mental health treatment.
  • You are not on an extended leave under British Columbia's Mental Health Act.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07314190Enrolling by invitation
Blood tests for brain diseases and mental health conditions

This study looks at blood tests to help diagnose and track brain diseases (like Alzheimer's) or mental health conditions. It compares patients to healthy volunteers to find better ways to detect and monitor these illnesses.

Barcelona
NCT07239843Enrolling by invitation
Study of blood markers and mental health in brain diseases

This study looks at how social factors and blood markers relate to psychiatric symptoms in people with brain diseases or mental disorders. It aims to find new ways to understand and diagnose these conditions.

Barcelona, Barcelona
NCT07738497Not yet recruiting
Precision treatment for depression using biomarkers

This study looks for genetic and biological markers to help doctors choose the best depression treatment for each person. It aims to make treatment more personalized and effective.

NCT06747364Recruiting
Blood test for recent alcohol use

This study looks at a blood test that may tell how much alcohol a person has had recently, even after they've stopped drinking. It may help doctors better understand drinking patterns and health risks.

Denton, Texas
NCT07649993Not yet recruiting
Gene activity markers in mental health conditions

This study looks at how certain molecules (called non-coding RNAs) relate to mental health conditions like bipolar disorder, depression, anxiety, OCD, or schizophrenia. By comparing patients who haven't been on psychiatric medication for at least 6 months with healthy volunteers, researchers hope to find better ways to diagnose and understand these conditions.

Catania, Sicily
NCT06507787Recruiting
Blood test for depression vs. bipolar disorder

This study tests a new blood test (EDIT-B®) to help doctors tell the difference between depression and bipolar disorder. If you have a depressive episode but there is doubt about bipolar disorder, this test might help guide your treatment to improve your health.

Erstein

Hear when a new Depression - Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.